Ventricular Assist Devices Market Size & Share, by Product Type {Biventricular, Right, Left}; Design (Implantable, Transcutaneous); Application {Bridge-to-Transplant, Bridge-to-Candidacy, Bridge-to-Transplant, Destination Therapy}; End-user (Specialty Clinics, Hospitals, ASCs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 1410
Published Date: Feb 06, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Ventricular Assist Devices Landscape

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Sun Medical Technology Research Corpï¼Å½
Berlin Heart GmbH
Abiomed, Inc.
ReliantHeart, Inc.
Jarvik Heart, Inc
LivaNova, Inc.
Boston Scientific Corporation
Calon cardio-Technology Ltd.
Medtronic plc

Browse Key Market Insights with Data Illustration:

Ventricular Assist Devices Market Size & Share, Growth Forecasts 2033

In the News

Abiomed, Inc. to unload with Impella CP for 30 minutes before percutaneous coronary intervention. Impella CP is associated with the patients having decreased Infarct size.
Abbott Laboratories to unveil its Amplatzer “Talisman”, a PFO Occlusion System. The system is developed to close the holes in the heart preventing the risk of heart stroke. The system is very beneficial for people living with patent foramen ovale (PFO).

Frequently Asked Questions (FAQ)

Rising penetration of stroke and increasing prevalence of coronary artery disease are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023-2033.

High costs associated with the requisite equipment and lack of skilled medical professionals are estimated to challenge the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Sun Medical Technology Research Corp., Berlin Heart GmbH, Abiomed, Inc., ReliantHeart, Inc., Jarvik Heart, Inc, LivaNova, Inc., Boston Scientific Corporation, Calon cardio-Technology Ltd., Medtronic plc, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, design, application, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Ventricular Assist Devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the ventricular assist devices market?

What would be the CAGR of ventricular assist devices market over the forecast period?

What are the challenges affecting the ventricular assist devices market growth?

Which region will provide more business opportunities for growth of ventricular assist devices market in future?

Who are the major players dominating the ventricular assist devices market?

How are the company profiles selected?

What are the segments in the ventricular assist devices market?

Which segment captures the largest market size in end-user in the ventricular assist devices market?